Status:

COMPLETED

Modern Pain Neuroscience Applied to Chronic Pain in Patients With Chronic Whiplash Associated Disorders

Lead Sponsor:

Vrije Universiteit Brussel

Collaborating Sponsors:

University Hospital, Ghent

University Ghent

Conditions:

Whiplash

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Modern pain neuroscience has advanced our understanding of chronic whiplash associated disorders (WAD). Previous studies have shown the importance of central sensitization, characterized by hypersensi...

Detailed Description

Modern pain neuroscience has advanced our understanding of chronic whiplash associated disorders (WAD). Previous studies have shown the importance of central sensitization, characterized by hypersensi...

Eligibility Criteria

Inclusion

  • Experienced a whiplash trauma which is at least 3 months old and causes pain since at least 3 months, with pain experience with a mean pain frequency of 3 or more days per week, and with self-reported moderate to severe pain-related disability, established by a score of 15 or more of a maximum of 50 on the Neck Disability Index
  • Patients classified as WAD II or WAD III on the modified Quebec Task Force Scale
  • Native Dutch speaker
  • Not starting new treatments or medication and continuing their usual care 6 weeks prior to and during study participation (to obtain a steady state)
  • Refraining from non-opioid analgesics in the previous 48h of the assessments
  • Refraining from caffeine, alcohol, and nicotine in the previous 24h of the assessments

Exclusion

  • Neuropathic pain
  • Being pregnant or having given birth in the preceding year
  • Chronic fatigue syndrome
  • Fibromyalgia
  • Cardiovascular disorders
  • Epilepsy
  • Endocrinological disorders
  • Rheumatic disorders
  • Psychiatric disorders
  • History of neck surgery
  • Loss of consciousness during/after the whiplash trauma
  • Post-traumatic amnesia

Key Trial Info

Start Date :

August 17 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 13 2022

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT03239938

Start Date

August 17 2017

End Date

June 13 2022

Last Update

November 28 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Sint-jozefkliniek Campus Bornem (AZ Rivierenland)

Bornem, Antwerpen, Belgium, 2880

2

Ghent University

Ghent, Oost-Vlaanderen, Belgium, 9000

3

Vrije Universiteit Brussel

Brussels, Belgium, 1000